Methyl 2,6-dihydroxy-4-methylbenzoate

CAS : 16846-10-9

Ref. 3D-FM70896

Informations sur le produit

• Nom: Methyl 2,6-dihydroxy-4-methylbenzoate
• Synonymes: 2,6-Dihydroxy-4-methylbenzoic acid methyl ester
• Marque: Biosynth
• Description: Methyl 2,6-dihydroxy-4-methylbenzoate is a compound that can be used to treat cancer. It inhibits the growth of cancer cells by binding to DNA and RNA molecules, which prevents transcription and replication. The drug also inhibits the production of usnic acid, an antioxidant that has been shown to have anticancer effects in vitro. Methyl 2,6-dihydroxy-4-methylbenzoate has been tested against a number of cancer cell lines including MDA-MB231 breast cancer cells and MCF7 breast cancer cells. This drug is not toxic to healthy cells at concentrations of up to 250 µM. At higher concentrations, methyl 2,6-dihydroxy-4-methylbenzoate may cause denaturation or cell death of cells due to its ability to attack DNA and RNA molecules.

Propriétés chimiques

• Masse moléculaire: 182.17 g/mol
• Formule: C₉H₁₀O₄
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C9H10O4/c1-5-3-6(10)8(7(11)4-5)9(12)13-2/h3-4,10-11H,1-2H3
• Code InChI: InChIKey=RIJMQNGJNNAAQK-UHFFFAOYSA-N
• SMILES: COC(=O)c1c(O)cc(C)cc1O